VCEL Vericel Corporation - Common Stock
NASDAQ · Biotechnology · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Lip 30, 2026
$40,15
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$28,9552tyg. minimum
$49,3252tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$2.05B
P/E (TTM)
83.6
EPS (TTM)
$0.48
Przychody (TTM)
$306M
Twoje odznaki
Zakres 52 tyg.
$29–$49
Ocena Analityków
BUY
Cena Docelowa
$61
P/E
83.6
ROE
7.2%
Marża Zysku Netto
7.9%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
VCEL Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$40.15
Kapitalizacja Rynkowa (MRQ)
$2.05B
P/E (TTM)
83.6
EPS (TTM)
$0.48
Przychody (TTM)
$306M
ROE (TTM)
7.2%
Zakres 52 tyg.
$29–$49
VCEL Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 16 października 2013 | 1-for-20 | Odwrotny |
| 18 lutego 2010 | 1-for-8 | Odwrotny |
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$276M2016-12-31 → 2025-12-31
EPS$0.322018-12-31 → 2025-12-31
Wolny przepływ pieniężny$25M2016-12-31 → 2025-12-31
Marża netto7.9%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | VCEL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 83.6średnia z 5 lat ≈-88.5 | ≈-88.5 | · | · | |
| P/S (TTM) | 6.7średnia z 5 lat ≈9.2 | ≈9.2 | 25.9 | Niedowartościowany | |
| P/B (MRQ) | 5.6średnia z 5 lat ≈7.9 | ≈7.9 | 6.2 | Wartość godziwa | |
| Cena / FCF (TTM) | 33.3średnia z 5 lat ≈-14.7 | ≈-14.7 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 29.5średnia z 5 lat ≈52.8 | ≈52.8 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 5.6średnia z 5 lat ≈8.0 | ≈8.0 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈2.1 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | VCEL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 74.6%średnia z 5 lat ≈70.1% | ≈70.1% | · | · | |
| Marża Operacyjna (TTM) | 6.0%średnia z 5 lat ≈-2.6% | ≈-2.6% | -668.2% | Najwyższa półka | |
| Marża EBITDA (TTM) | 10.2%średnia z 5 lat ≈0.08% | ≈0.08% | -668.2% | Najwyższa półka | |
| Pretax Margin (Marża przed opodatkowaniem) | 6.3%średnia z 5 lat ≈-1.0% | ≈-1.0% | -765.9% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 7.9%średnia z 5 lat ≈-1.2% | ≈-1.2% | -669.0% | Najwyższa półka | |
| ROA (TTM) | 5.2%średnia z 5 lat ≈-0.92% | ≈-0.92% | -42.9% | Najwyższa półka | |
| ROE (TTM) | 7.2%średnia z 5 lat ≈-1.3% | ≈-1.3% | -80.2% | Najwyższa półka | |
| ROIC | 3.0%średnia z 5 lat ≈-2.6% | ≈-2.6% | -119.4% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | VCEL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 5.0średnia z 5 lat ≈5.0 | ≈5.0 | 6.0 | Poniżej średniej | |
| Wskaźnik Szybkości (MRQ) | 4.5średnia z 5 lat ≈4.3 | ≈4.3 | 4.4 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | VCEL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 16.4%średnia z 5 lat ≈17.5% | ≈17.5% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 18.9%średnia z 5 lat ≈16.9% | ≈16.9% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 17.3% | · | · | · | |
| EPS YoY | 60.0% | · | · | · | |
| Net Income YoY (Zysk Netto R/R) | 59.4% | · | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 39.8% | · | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 42.0% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | VCEL | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.6 | ≈0.6 | 0.1 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 4.0średnia z 5 lat ≈4.1 | ≈4.1 | 2.0 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 3.8średnia z 5 lat ≈4.0 | ≈4.0 | 7.2 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$694.1K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
53.3%
Następny raport
Lis 04, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 29, 2026 | $0.04 | $-0.03 | 239.4% |
| 31 marca 2026 | Maj 13, 2026 | $-0.12 | $-0.16 | 24.1% |
| 31 grudnia 2025 | $0.45 | $0.40 | 13.1% | |
| 30 września 2025 | $0.10 | $-0.01 | — | |
| 30 czerwca 2025 | $-0.01 | $-0.03 | 68.7% | |
| 31 marca 2025 | $-0.23 | $-0.13 | -78.6% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $276M | $237M | $198M | $164M | $156M | $124M | $118M | $91M | $64M | $54M | $51M | $29M | |
| Cost of Revenue | $71M | $65M | $62M | $55M | $50M | $40M | $38M | $32M | $30M | $28M | $26M | $17M | |
| Gross Profit | $206M | $172M | $136M | $110M | $106M | $84M | $80M | $59M | $34M | $26M | $25M | $12M | |
| R&D Expense | $28M | $25M | $21M | $20M | $16M | $13M | $30M | $14M | $13M | $15M | $19M | $21M | |
| SG&A Expense | $167M | $143M | $121M | $107M | $98M | $69M | $61M | $49M | $36M | $27M | $22M | $14M | |
| Operating Expenses | $195M | $168M | $142M | $127M | $114M | $82M | $92M | $63M | $49M | $45M | $41M | $35M | |
| Operating Income | $11M | $5M | $-6M | $-17M | $-8M | $2M | $-11M | $-4M | $-15M | $-19M | $-17M | $-24M | |
| Interest Expense | · | · | $600.0K | $366.0K | $4.0K | $6.0K | $8.0K | $31.0K | $92.0K | $15.0K | $9.0K | $6.0K | |
| Interest Income | $7M | $6M | $5M | $1M | $224.0K | $691.0K | $2M | $897.0K | $14.0K | $8.0K | $36.0K | $24.0K | |
| Other Non-op | $-44.0K | $195.0K | $64.0K | $95.0K | $52.0K | $-13.0K | $-20.0K | $-2M | $-1M | $-314.0K | $-20.0K | $-2.0K | |
| Pretax Income | $17M | $11M | $-2M | $-16M | $-8M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| Income Tax | $859.0K | $148.0K | $814.0K | $721.0K | $-111.0K | $180.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $17M | $10M | $-3M | $-17M | $-7M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| EPS (Basic) | $0.33 | $0.21 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · | |
| EPS (Diluted) | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · | |
| Shares (Basic) | 50,340,000 | 48,848,000 | 47,590,000 | 47,130,000 | 46,472,000 | 45,221,000 | 44,180,000 | 40,242,000 | · | · | · | · | |
| Shares (Diluted) | 52,151,000 | 51,679,000 | 47,590,000 | 47,130,000 | 46,472,000 | 47,282,000 | 44,180,000 | 40,242,000 | · | · | · | · | |
| EBITDA | $23M | $10M | $-2M | $-13M | $-5M | $5M | $-10M | $-2M | $-13M | $-17M | $-15M | $-23M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $75M | $69M | $51M | $68M | $34M | $27M | $18M | $27M | $23M | $15M | $30M | |
| Short-term Investments | $37M | $42M | $40M | $68M | $35M | $42M | $43M | $65M | $0 | · | · | · | |
| Receivables | $85M | $61M | $58M | $47M | $37M | $35M | $32M | $23M | $18M | $17M | $11M | $8M | |
| Inventory | $18M | $17M | $13M | $16M | $13M | $9M | $7M | $4M | $4M | $3M | $1M | $2M | |
| Other Current Assets | $8M | $7M | $7M | $5M | $4M | $4M | $3M | $3M | $2M | $1M | $464.0K | $1M | |
| Current Assets | $247M | $213M | $206M | $187M | $158M | $124M | $112M | $113M | $51M | $45M | $27M | $41M | |
| PP&E (Net) | · | · | · | · | · | · | · | $6M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $13M | $11M | $11M | $10M | $7M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $8M | $7M | $7M | $6M | $4M | |
| Intangibles | $6M | $6M | $7M | $8M | $0 | · | · | · | · | $0 | $3M | $3M | |
| Other Non-current Assets | $341.0K | $556.0K | $771.0K | $1M | $317.0K | $0 | · | · | · | · | · | · | |
| Total Assets | $488M | $433M | $354M | $273M | $244M | $206M | $153M | $119M | $55M | $49M | $34M | $48M | |
| Accounts Payable | $16M | $24M | $22M | $17M | $9M | $7M | $6M | $7M | $6M | $7M | $8M | $6M | |
| Accrued Liabilities | $19M | $17M | $17M | $16M | $14M | $11M | $8M | $7M | $6M | $5M | $4M | $5M | |
| Current Liabilities | $49M | $50M | $46M | $37M | $26M | $22M | $20M | $15M | $13M | $13M | $12M | $12M | |
| Capital Leases | $82M | $90M | $82M | $43M | $47M | $49M | $22M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $2M | $876.0K | $100.0K | $0 | $44.0K | $76.0K | $110.0K | $2M | · | $32.0K | · | $0 | |
| Total Liabilities | $133M | $141M | $128M | $81M | $73M | $71M | $42M | $16M | $32M | $24M | $12M | $12M | |
| Common Stock | $731M | $685M | $629M | $593M | $554M | $510M | $490M | $471M | $383M | $330M | $308M | $305M | |
| Retained Earnings | $-376M | $-393M | $-403M | $-400M | $-383M | $-376M | $-379M | $-369M | $-361M | $-344M | $-324M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| AOCI | $275.0K | $4.0K | $-100.0K | $-978.0K | $-154.0K | $14.0K | $21.0K | $-39.0K | $0 | $190.0K | $0 | $-71.0K | |
| Stockholders' Equity | $355M | $292M | $226M | $192M | $170M | $134M | $111M | $102M | $23M | $25M | $22M | $36M | |
| Liabilities + Equity | $488M | $433M | $354M | $273M | $244M | $206M | $153M | $119M | $55M | $49M | $34M | $48M | |
| Shares Outstanding | 50,620,000 | 49,628,000 | 47,829,000 | 47,253,000 | 46,880,000 | 45,804,000 | 44,864,000 | 43,578,000 | 35,861,000 | 31,595,000 | 23,789,000 | 23,786,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $6M | $5M | $4M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $752.0K | |
| Stock-based Comp | $39M | $36M | $32M | $37M | $34M | $14M | $13M | $7M | $3M | $2M | $3M | $839.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | $300.0K | $300.0K | $200.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $100.0K | · | $3M | |
| Other Non-cash | $-15M | $6M | $2M | $-7M | $-811.0K | $-2M | $-12M | $-924.0K | $-189.0K | $-5M | $-1M | $-7M | |
| Operating Cash Flow | $52M | $58M | $35M | $18M | $29M | $18M | $-7M | $-412.0K | $-13M | $-20M | $-13M | $-25M | |
| CapEx | $27M | $64M | $20M | $8M | $8M | $3M | $3M | $3M | $2M | $1M | $2M | $829.0K | |
| Investing Cash Flow | $-44M | $-79M | $-3M | $-36M | $-4M | $-17M | $11M | $-67M | $-2M | $-1M | $-2M | · | |
| Stock Issued | $14M | $25M | $6M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $14M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $7M | $19M | $4M | $1M | $9M | $6M | $5M | $59M | $19M | $30M | $-24.0K | · | |
| Net Change in Cash | $15M | $-2M | $36M | $-17M | $35M | $7M | $9M | $-9M | $4M | · | · | · | |
| Taxes Paid | $580.0K | $628.0K | $1M | $0 | $379.0K | $147.0K | $80.0K | · | · | · | · | · | |
| Free Cash Flow | $25M | $-6M | $15M | $10M | $21M | $15M | $-10M | $-3M | $-15M | $-21M | $-16M | $-26M | |
| Levered FCF | · | · | $14M | $10M | $21M | $15M | $-10M | $-3M | $-16M | $-22M | $-16M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.4% | 72.5% | 68.6% | 66.8% | 67.9% | 67.8% | 68.1% | 64.6% | 52.5% | 47.9% | 48.3% | 40.0% | |
| Operating Margin | 4.0% | 1.9% | -3.3% | -10.4% | -5.0% | 1.9% | -9.6% | -4.3% | -23.4% | -35.4% | -32.6% | -81.7% | |
| Net Margin | 6.0% | 4.4% | -1.6% | -10.2% | -4.8% | 2.3% | -8.2% | -9.0% | -27.0% | -36.0% | -31.9% | -69.2% | |
| Pretax Margin | 6.3% | 4.4% | -1.2% | -9.7% | -4.9% | 2.5% | -8.2% | -9.0% | -27.0% | -36.0% | -31.9% | -69.2% | |
| EBITDA Margin | 8.2% | 4.2% | -0.93% | -8.0% | -3.1% | 3.8% | -8.1% | -2.7% | -20.9% | -31.9% | -29.5% | -79.1% | |
| ROA | 3.6% | 2.6% | -1.0% | -6.5% | -3.3% | 1.6% | -7.1% | -9.4% | -33.5% | -47.2% | -39.9% | -70.2% | |
| ROE | 5.0% | 3.8% | -1.5% | -9.0% | -4.6% | 2.3% | -9.3% | -8.3% | -73.2% | -83.5% | -56.6% | -100.8% | |
| ROIC | 3.0% | 1.5% | -3.8% | -9.3% | -4.5% | 1.7% | -10.1% | -3.8% | -66.5% | -77.9% | -75.3% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.2 | 4.5 | 5.0 | 6.1 | 5.5 | 5.6 | 7.6 | 3.9 | 3.5 | 2.3 | 3.5 | |
| Quick Ratio | 4.5 | 3.5 | 3.7 | 4.4 | 5.4 | 4.9 | 5.1 | 7.2 | 3.4 | 3.1 | 2.1 | 3.3 | |
| Interest Coverage | · | · | -10.8 | -46.6 | -1963.5 | 182.5 | -562.5 | -126.1 | -13.5 | -61.3 | -1852.3 | -3922.3 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.9 | 1.0 | 1.2 | 1.3 | 1.2 | 1.0 | |
| Inventory Turnover | 4.0 | 4.3 | 4.3 | 3.7 | 4.4 | 4.9 | 7.2 | 8.7 | 8.3 | 11.6 | 16.0 | 18.0 | |
| Receivables Turnover | 3.8 | 4.0 | 3.8 | 3.9 | 4.3 | 3.7 | 4.2 | 4.4 | 3.6 | 3.9 | 5.4 | 7.0 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.01 | $5.88 | $4.72 | $4.07 | $3.64 | $2.93 | $2.48 | $2.35 | $0.63 | $0.78 | $0.93 | $1.50 | |
| Revenue / Share | $5.30 | $4.59 | $4.15 | $3.49 | $3.36 | $2.63 | · | · | · | · | · | · | |
| Cash Flow / Share | $1.00 | $1.13 | $0.74 | $0.38 | $0.62 | $0.37 | · | · | · | · | · | · | |
| Cash / Share | $1.98 | $1.50 | $1.44 | $1.08 | $1.46 | $0.73 | $0.60 | $0.42 | $0.75 | $0.73 | $0.61 | $1.28 | |
| EPS (TTM) | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 | $0.06 | $-0.22 | $-0.20 | · | · | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.4% | 20.1% | 20.2% | 5.2% | 25.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.9% | 14.9% | 16.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 39.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 59.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 42.0% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $276M | $237M | $198M | $164M | $156M | $124M | $118M | $91M | $64M | $54M | $51M | $29M | |
| Net Income TTM | $17M | $10M | $-3M | $-17M | $-7M | $3M | $-10M | $-8M | $-17M | $-20M | $-16M | $-20M | |
| Market Cap | $1.82B | $2.73B | $1.70B | $1.24B | $1.84B | $1.41B | $781M | $758M | $195M | $95M | $61M | $72M | |
| P/E | 112.5 | 274.6 | -508.7 | -75.3 | -245.6 | 514.7 | -79.1 | -87.0 | · | · | · | · | |
| P/S | 6.6 | 11.5 | 8.6 | 7.6 | 11.8 | 11.4 | 6.6 | 8.3 | 3.1 | 1.7 | 1.2 | 2.5 | |
| P/B | 5.1 | 9.3 | 7.5 | 6.5 | 10.8 | 10.5 | 7.0 | 7.4 | 8.7 | 3.8 | 2.8 | 2.0 | |
| P / Tangible Book | 5.2 | 9.5 | 7.8 | 6.7 | 10.8 | 10.5 | · | · | · | · | · | · | |
| P / Cash Flow | 35.1 | 46.9 | 48.2 | 70.4 | 63.4 | 80.5 | -108.7 | -1840.4 | -14.8 | -4.8 | -4.6 | -2.8 | |
| P / FCF | 73.7 | -469.0 | 111.3 | 123.3 | 87.2 | 94.6 | -79.7 | -245.4 | -13.3 | -4.4 | -3.9 | -2.8 | |
| Earnings Yield | 0.89% | 0.36% | -0.20% | -1.3% | -0.41% | 0.19% | -1.3% | -1.1% | · | · | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $77M | $68M | $93M | $68M | $63M | $53M | $75M | $58M | $53M | $51M | $65M | $46M | $46M | $41M | $53M | $39M | |
| Cost of Revenue | $21M | $19M | $20M | $18M | $17M | $16M | $17M | $16M | $16M | $16M | $16M | $15M | $16M | $14M | $14M | $13M | |
| Gross Profit | $56M | $49M | $73M | $50M | $47M | $36M | $58M | $42M | $37M | $35M | $49M | $31M | $30M | $27M | $38M | $25M | |
| R&D Expense | $7M | $8M | $7M | $6M | $7M | $7M | $5M | $6M | $7M | $6M | $5M | $6M | $5M | $5M | $5M | $5M | |
| SG&A Expense | $48M | $49M | $43M | $40M | $42M | $42M | $35M | $38M | $35M | $34M | $31M | $30M | $31M | $29M | $27M | $27M | |
| Operating Expenses | $56M | $57M | $51M | $46M | $49M | $49M | $40M | $44M | $43M | $41M | $36M | $36M | $36M | $35M | $32M | $32M | |
| Operating Income | $434.0K | $-8M | $22M | $3M | $-2M | $-13M | $18M | $-2M | $-6M | $-5M | $13M | $-5M | $-6M | $-8M | $6M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $153.0K | · | $150.0K | $149.0K | $145.0K | · | $105.0K | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $839.0K | $763.0K | $342.0K | |
| Other Non-op | $-22.0K | $71.0K | $-36.0K | $-26.0K | $-24.0K | $42.0K | $70.0K | $140.0K | $-8.0K | $-7.0K | $-2M | $-1.0K | $941.0K | $682.0K | $-3.0K | $-5.0K | |
| Pretax Income | · | · | · | · | · | · | $20M | $-901.0K | · | · | $14M | $-4M | · | · | $7M | $-7M | |
| Income Tax | · | · | · | · | · | · | $148.0K | $0 | · | · | $1M | $-286.0K | · | · | $700.0K | $21.0K | |
| Net Income | $2M | $-6M | $23M | $5M | $-553.0K | $-11M | $20M | $-901.0K | $-5M | $-4M | $13M | $-4M | $-5M | $-7M | $6M | $-7M | |
| EPS (Basic) | $0.04 | $-0.12 | $0.47 | $0.10 | $-0.01 | $-0.23 | $0.41 | $-0.02 | $-0.10 | $-0.08 | $0.28 | $-0.08 | $-0.11 | $-0.16 | $0.13 | $-0.14 | |
| EPS (Diluted) | $0.04 | $-0.12 | $0.46 | $0.10 | $-0.01 | $-0.23 | $0.40 | $-0.02 | $-0.10 | $-0.08 | $0.28 | $-0.08 | $-0.11 | $-0.16 | $0.13 | $-0.14 | |
| Shares (Basic) | 51,075,000 | 50,773,000 | · | 50,489,000 | 50,368,000 | 49,905,000 | · | 49,085,000 | 48,686,000 | 48,141,000 | · | 47,649,000 | 47,572,000 | 47,387,000 | · | 47,182,000 | |
| Shares (Diluted) | 52,312,000 | 50,773,000 | · | 51,908,000 | 50,368,000 | 49,905,000 | · | 49,085,000 | 48,686,000 | 48,141,000 | · | 47,649,000 | 47,572,000 | 47,387,000 | · | 47,182,000 | |
| EBITDA | $434.0K | $-5M | · | $3M | $-2M | $-10M | · | $-2M | $-6M | $-4M | · | $-5M | $-6M | $-7M | · | $-6M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $109M | $100M | $100M | $81M | $73M | $75M | $54M | $50M | $63M | $69M | $60M | $43M | $62M | $51M | $65M | |
| Short-term Investments | $37M | $36M | $37M | $35M | $36M | $39M | $42M | $48M | $52M | $48M | · | $45M | $55M | $57M | · | $46M | |
| Receivables | $76M | $72M | $85M | $60M | $64M | $53M | $61M | $48M | $48M | $50M | · | $40M | $38M | $38M | · | $34M | |
| Inventory | $18M | $18M | $18M | $18M | $17M | $17M | $17M | $16M | $15M | $14M | · | $13M | $14M | $15M | · | $17M | |
| Other Current Assets | $8M | $8M | $8M | $8M | $7M | $9M | $7M | $8M | $6M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Assets | $265M | $244M | $247M | $222M | $205M | $198M | $213M | $191M | $197M | $190M | · | $186M | $183M | $178M | · | $166M | |
| Intangibles | $5M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $7M | $7M | · | $7M | $7M | $7M | · | · | |
| Other Non-current Assets | $233.0K | $288.0K | $341.0K | $395.0K | $447.0K | $501.0K | $556.0K | $610.0K | $664.0K | $717.0K | · | $1M | $1M | $1M | · | $1M | |
| Total Assets | $503M | $486M | $488M | $453M | $436M | $425M | $433M | $390M | $377M | $357M | · | $318M | $311M | $265M | · | $248M | |
| Accounts Payable | $21M | $19M | $16M | $15M | $13M | $17M | $24M | $21M | $25M | $19M | · | $15M | $14M | $11M | · | $8M | |
| Accrued Liabilities | $18M | $14M | $19M | $16M | $14M | $11M | $17M | $14M | $13M | $11M | · | $14M | $14M | $13M | · | $14M | |
| Current Liabilities | $53M | $47M | $49M | $46M | $41M | $39M | $50M | $41M | $44M | $36M | · | $36M | $36M | $29M | · | $27M | |
| Capital Leases | $78M | $80M | $82M | $84M | $86M | $88M | $90M | $91M | $90M | $86M | · | $78M | $76M | $42M | · | $43M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $876.0K | $243.0K | $198.0K | $154.0K | · | $65.0K | $28.0K | · | · | $0 | |
| Total Liabilities | $133M | $129M | $133M | $131M | $129M | $129M | $141M | $133M | $134M | $123M | · | $114M | $112M | $71M | · | $70M | |
| Common Stock | $751M | $739M | $731M | $721M | $711M | $699M | $685M | $670M | $655M | $641M | · | $621M | $612M | $602M | · | $585M | |
| Retained Earnings | $-380M | $-383M | $-376M | $-400M | $-405M | $-404M | $-393M | $-413M | $-412M | $-407M | · | $-416M | $-413M | $-407M | · | $-406M | |
| AOCI | $-365.0K | $-168.0K | $275.0K | $258.0K | $183.0K | $136.0K | $4.0K | $359.0K | $-273.0K | $-245.0K | · | $-463.0K | $-621.0K | $-636.0K | · | $-1M | |
| Stockholders' Equity | $370M | $356M | $355M | $322M | $307M | $295M | $292M | $257M | $243M | $234M | $226M | $204M | $199M | $194M | $192M | $178M | |
| Liabilities + Equity | $503M | $486M | $488M | $453M | $436M | $425M | $433M | $390M | $377M | $357M | · | $318M | $311M | $265M | · | $248M | |
| Shares Outstanding | 51,171,000 | 51,010,000 | 50,620,000 | 50,550,000 | 50,441,000 | 50,252,000 | 49,628,000 | 49,265,000 | 48,862,000 | 48,489,000 | 47,829,000 | 47,684,000 | 47,616,000 | 47,507,000 | 47,253,000 | 47,201,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $3M | $3M | $3M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $9M | $11M | $8M | $9M | $10M | $12M | $8M | $9M | $10M | $10M | $7M | $8M | $9M | $9M | $8M | $9M | |
| Other Non-cash | · | $8M | · | · | · | $4M | · | · | · | $-148.0K | · | · | · | $5M | · | · | |
| Operating Cash Flow | $16M | $16M | $15M | $22M | $8M | $7M | $22M | $10M | $19M | $7M | $10M | $7M | $10M | $8M | $7M | $4M | |
| CapEx | $2M | $1M | $2M | $3M | $8M | $14M | $14M | $19M | $17M | $14M | $8M | $7M | $4M | $1M | $1M | $1M | |
| Investing Cash Flow | $-3M | $-4M | $-16M | $-3M | $-9M | $-15M | $-15M | $-21M | $-18M | $-25M | $-8M | $5M | $-2M | $3M | $-22M | $-811.0K | |
| Stock Issued | $3M | $2M | $1M | $1M | $2M | $9M | $7M | $6M | $4M | $7M | $1M | $1M | $1M | $2M | · | $829.0K | |
| Net Stock Activity | · | $2M | · | · | · | $9M | · | · | · | $7M | · | · | · | $2M | · | · | |
| Financing Cash Flow | $3M | $-3M | $1M | $1M | $2M | $3M | $7M | $6M | $4M | $2M | $1M | $1M | $1M | $107.0K | $605.0K | $-312.0K | |
| Net Change in Cash | $16M | $9M | $-311.0K | $20M | $827.0K | $-5M | $15M | $-6M | $5M | $-16M | $3M | $13M | $9M | $11M | $-14M | $3M | |
| Free Cash Flow | · | $15M | · | · | · | $-8M | · | · | · | $-7M | · | · | · | $6M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.8% | 72.0% | · | 73.5% | 73.7% | 69.0% | · | 71.9% | 69.5% | 68.9% | · | 67.2% | 65.2% | 64.7% | · | 65.5% | |
| Operating Margin | 0.56% | -11.8% | · | 5.1% | -3.2% | -24.3% | · | -4.3% | -11.5% | -10.7% | · | -11.1% | -13.0% | -19.9% | · | -17.6% | |
| Net Margin | 2.9% | -9.2% | · | 7.5% | -0.87% | -21.4% | · | -1.6% | -8.9% | -7.5% | · | -8.0% | -10.9% | -18.3% | · | -17.1% | |
| Pretax Margin | · | · | · | · | · | · | · | -1.6% | · | · | · | -8.7% | · | · | · | -17.0% | |
| EBITDA Margin | 0.56% | -7.0% | · | 5.1% | -3.2% | -19.2% | · | -4.3% | -11.5% | -8.0% | · | -11.1% | -13.0% | -17.1% | · | -15.0% | |
| ROA | 0.47% | -1.4% | · | 1.2% | -0.14% | -2.9% | · | -0.25% | -1.4% | -1.2% | · | -1.3% | -1.8% | -3.0% | · | -2.8% | |
| ROE | 0.65% | -1.9% | · | 1.8% | -0.20% | -4.2% | · | -0.39% | -2.1% | -1.8% | · | -1.9% | -2.7% | -4.1% | · | -3.9% | |
| ROIC | · | · | · | · | · | · | · | -0.96% | · | · | · | -2.3% | · | · | · | -3.8% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.2 | · | 4.9 | 5.0 | 5.0 | · | 4.6 | 4.5 | 5.2 | · | 5.2 | 5.1 | 6.2 | · | 6.2 | |
| Quick Ratio | 4.5 | 4.6 | · | 4.3 | 4.4 | 4.2 | · | 3.6 | 3.4 | 4.4 | · | 4.0 | 3.8 | 5.5 | · | 5.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.7 | · | -33.7 | -40.0 | -56.4 | · | -64.6 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 0.9 | |
| Receivables Turnover | 1.1 | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.2 | · | 1.2 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.23 | $6.98 | · | $6.37 | $6.08 | $5.88 | · | $5.23 | $4.97 | $4.82 | · | $4.29 | $4.18 | $4.08 | · | $3.77 | |
| Revenue / Share | $1.48 | $1.35 | · | $1.30 | $1.26 | $1.05 | · | $1.18 | $1.08 | $1.07 | · | $0.96 | $0.97 | $0.87 | · | $0.82 | |
| Cash Flow / Share | · | $0.32 | · | · | · | $0.13 | · | · | · | $0.15 | · | · | · | $0.17 | · | · | |
| Cash / Share | $2.45 | $2.14 | · | $1.99 | $1.60 | $1.46 | · | $1.09 | $1.03 | $1.30 | · | $1.27 | $0.90 | $1.30 | · | $1.38 | |
| EPS (TTM) | $0.48 | $0.43 | · | $0.26 | $0.14 | $0.05 | · | $0.08 | $0.02 | $0.01 | · | $-0.22 | $-0.28 | $-0.36 | · | $-0.38 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $306M | $292M | · | $259M | $249M | $239M | · | $227M | $215M | $208M | · | $185M | $178M | $169M | · | $159M | |
| Net Income TTM | $24M | $21M | · | $13M | $7M | $3M | · | $4M | $789.0K | $451.0K | · | $-10M | $-13M | $-17M | · | $-18M | |
| Market Cap | $2.28B | $1.64B | · | $1.59B | $2.15B | $2.24B | · | $2.08B | $2.24B | $2.52B | · | $1.60B | $1.79B | $1.39B | · | $1.10B | |
| P/E | 92.7 | 74.8 | · | 121.0 | 303.9 | 892.4 | · | 528.1 | 2294.0 | 5202.0 | · | -152.4 | -134.2 | -81.4 | · | -61.1 | |
| P/S | 7.4 | 5.6 | · | 6.1 | 8.6 | 9.4 | · | 9.2 | 10.5 | 12.1 | · | 8.6 | 10.0 | 8.2 | · | 6.9 | |
| P/B | 6.2 | 4.6 | · | 4.9 | 7.0 | 7.6 | · | 8.1 | 9.2 | 10.8 | · | 7.8 | 9.0 | 7.2 | · | 6.2 | |
| P / Tangible Book | 6.2 | 4.7 | · | 5.0 | 7.1 | 7.7 | · | 8.3 | 9.5 | 11.1 | · | 8.1 | 9.3 | 7.5 | · | 6.2 | |
| P / Cash Flow | · | 100.2 | · | · | · | 339.7 | · | · | · | 350.2 | · | · | · | 177.2 | · | · | |
| Earnings Yield | 1.1% | 1.3% | · | 0.83% | 0.33% | 0.11% | · | 0.19% | 0.04% | 0.02% | · | -0.66% | -0.75% | -1.2% | · | -1.6% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $276M | $237M | $198M | $164M | $156M |
| Marża Brutto % | 74.4% | 72.5% | 68.6% | 66.8% | 67.9% |
| Marża Operacyjna % | 4.0% | 1.9% | -3.3% | -10.4% | -5.0% |
| Zysk netto | $17M | $10M | $-3M | $-17M | $-7M |
| Rozwodniony EPS | $0.32 | $0.20 | $-0.07 | $-0.35 | $-0.16 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.0 | 4.2 | 4.5 | 5.0 | 6.1 |
| Wskaźnik Szybkości | 4.5 | 3.5 | 3.7 | 4.4 | 5.4 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $25M | $-6M | $15M | $10M | $21M |
Właściciele instytucjonalni (13F) 335 emitentów · $2.5B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
335
Wartość posiadanych akcji
$2.5B
Nowe pozycje
65
Zamknięte pozycje
22
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 65 (+19 vs poprzedni kw.) | 22 (-6 vs poprzedni kw.) | 119 (+19 vs poprzedni kw.) | 96 (+1 vs poprzedni kw.) | -2.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $360 023 135 | 8 092 226 | 14,42% | Akcje |
| STATE STREET CORP | $146 576 910 | 3 293 975 | 5,87% | Akcje |
| CONGRESS ASSET MANAGEMENT CO | $129 745 965 | 2 916 295 | 5,20% | Akcje |
| VANGUARD GROUP INC | $129 060 056 | 3 584 006 | 5,17% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $100 357 339 | 2 255 728 | 4,02% | Akcje |
| Conestoga Capital Advisors, LLC | $92 709 686 | 2 083 832 | 3,71% | Akcje |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $88 662 119 | 1 992 855 | 3,55% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $72 963 066 | 1 639 988 | 2,92% | Akcje |
| Soleus Capital Management, L.P. | $64 917 672 | 1 459 152 | 2,60% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $59 683 458 | 1 341 244 | 2,39% | Akcje |
| GENEVA CAPITAL MANAGEMENT LLC | $59 577 597 | 1 339 123 | 2,39% | Akcje |
| LOOMIS SAYLES & CO L P | $53 398 633 | 1 200 239 | 2,14% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $47 192 901 | 1 060 753 | 1,89% | Akcje |
| BANK OF AMERICA CORP /DE/ | $45 210 026 | 1 016 184 | 1,81% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $40 318 991 | 906 200 | 1,61% | Akcje |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $39 892 003 | 896 651 | 1,60% | Akcje |
| ROYAL BANK OF CANADA | $34 514 000 | 775 762 | 1,38% | Akcje |
| Champlain Investment Partners, LLC | $33 626 788 | 755 828 | 1,35% | Akcje |
| Aberdeen Group plc | $31 598 489 | 710 238 | 1,27% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $29 555 000 | 664 305 | 1,18% | Akcje |
| NEXT CENTURY GROWTH INVESTORS LLC | $27 253 862 | 612 584 | 1,09% | Akcje |
| NORTHERN TRUST CORP | $26 589 047 | 597 641 | 1,06% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $25 847 889 | 580 982 | 1,04% | Akcje |
| SG Capital Management LLC | $25 415 001 | 571 252 | 1,02% | Akcje |
| Nuveen, LLC | $23 388 571 | 525 704 | 0,94% | Akcje |
| GOLDMAN SACHS GROUP INC | $23 384 834 | 525 620 | 0,94% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $22 601 498 | 508 013 | 0,91% | Akcje |
| BROWN CAPITAL MANAGEMENT LLC | $22 425 140 | 504 049 | 0,90% | Akcje |
| D. E. Shaw & Co., Inc. | $20 122 338 | 452 289 | 0,81% | Akcje |
| Point72 Asset Management, L.P. | $19 724 019 | 443 336 | 0,79% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $19 718 323 | 443 208 | 0,79% | Akcje |
| SEI INVESTMENTS CO | $19 575 154 | 439 990 | 0,78% | Akcje |
| TimesSquare Capital Management, LLC | $18 604 973 | 578 333 | 0,75% | Akcje |
| MORGAN STANLEY | $17 976 724 | 404 062 | 0,72% | Akcje |
| OSTERWEIS CAPITAL MANAGEMENT INC | $17 723 259 | 398 365 | 0,71% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $16 262 385 | 365 529 | 0,65% | Akcje |
| UBS Group AG | $15 683 927 | 352 527 | 0,63% | Akcje |
| Balyasny Asset Management L.P. | $15 382 818 | 345 759 | 0,62% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $14 696 044 | 330 322 | 0,59% | Akcje |
| Invesco Ltd. | $13 755 507 | 309 182 | 0,55% | Akcje |
| JPMORGAN CHASE & CO | $13 527 202 | 297 759 | 0,54% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $12 605 256 | 283 328 | 0,50% | Akcje |
| Bank of New York Mellon Corp | $12 366 330 | 277 958 | 0,50% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $12 230 998 | 274 916 | 0,49% | Akcje |
| Woodline Partners LP | $12 090 291 | 271 753 | 0,48% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $11 107 952 | 249 673 | 0,44% | Akcje |
| JANE STREET GROUP, LLC | $11 041 216 | 248 173 | 0,44% | Akcje |
| FEDERATED HERMES, INC. | $10 304 551 | 231 615 | 0,41% | Akcje |
| AMERIPRISE FINANCIAL INC | $8 806 261 | 197 938 | 0,35% | Akcje |
| PEREGRINE CAPITAL MANAGEMENT LLC | $8 254 185 | 185 529 | 0,33% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Niezgłoszona osoba raportująca | 2 marca 2005 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca | 7 września 2004 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 39 insiderów · 16 dyrektorzy generalni · 14 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dominick Colangelo | President and CEO | 24 lutego 2026 M | 312 446 | 0 | 0 | $0 |
| Timothy M Mayleben | President and CEO | 29 sierpnia 2012 A | 133 000 | 0 | 0 | $0 |
| Joseph Anthony Mara Jr | Chief Financial Officer | 26 czerwca 2026 S | 16 009 | 0 | 2 | $-426 250 |
| Gerard J Michel | CFO and VP, Corp. Development | 1 kwietnia 2020 M | 253 865 | 0 | 0 | $0 |
| Scott Durbin | CFO | 4 stycznia 2012 S | 0 | 0 | 0 | $0 |
| Gerald Brennan JR | VP Admin. and Finance, CFO | 30 listopada 2007 A | 30 000 | 0 | 0 | $0 |
| Alan M Wright | SVP, CFO | 12 sierpnia 2004 A | 50 000 | 0 | 0 | $0 |
| Daniel Orlando | Chief Operating Officer | 6 lutego 2019 A | 58 191 | 0 | 0 | $0 |
| Jonathan Siegal | Principal Accounting Officer | 30 lipca 2026 M | 1 078 | 0 | 7 | $-530 762 |
| Sean C. Flynn | Chief Legal Officer | 26 czerwca 2026 M | 1 647 | 0 | 4 | $-2 041 280 |
| Jonathan Mark Hopper | Chief Medical Officer | 26 czerwca 2026 M | 75 753 | 0 | 5 | $-789 304 |
| Karen Mahoney | Chief Human Resources Officer | 22 lipca 2025 M | 1 854 | 0 | 0 | $0 |
| Michael W. Elliston | Controller | 3 stycznia 2014 A | · | 0 | 0 | $0 |
| Sharon Watling | VP Clinical Development | 25 czerwca 2012 A | · | 0 | 0 | $0 |
| Ronnda Bartel | Chief Scientific Officer | 25 czerwca 2012 A | · | 0 | 0 | $0 |
| Brian Gibson | Vice President | 3 maja 2012 A | · | 0 | 0 | $0 |
| Paul K Wotton | Dyrektor | 11 maja 2026 S | 18 802 | 0 | 4 | $-516 925 |
| Lisa Wright | Dyrektor | 29 kwietnia 2026 A | 15 851 | 0 | 0 | $0 |
| Heidi Hagen | Dyrektor | 29 kwietnia 2026 A | 35 050 | 0 | 1 | $-486 150 |
| Alan L Rubino | Dyrektor | 29 kwietnia 2026 A | 64 194 | 0 | 0 | $0 |
| Robert L Zerbe MD | Dyrektor | 29 kwietnia 2026 A | 32 995 | 0 | 0 | $0 |
| Steven C Gilman | Dyrektor | 16 października 2024 M | 11 000 | 0 | 0 | $0 |
| Nelson M Simms | Dyrektor | 20 marca 2015 A | 225 000 | 0 | 0 | $0 |
| Ronald M Cresswell | Dyrektor | 2 maja 2013 A | 40 000 | 0 | 0 | $0 |
| Harold C Urschel Jr | Dyrektor | 23 października 2012 A | · | 0 | 0 | $0 |
| George W Dunbar JR | Dyrektor | 11 marca 2010 A | 12 750 | 0 | 0 | $0 |
| Susan Wyant | Dyrektor | 7 listopada 2007 A | 6 900 | 0 | 0 | $0 |
| Douglas R Armstrong PHD | Dyrektor | 17 lipca 2006 A | 577 063 | 0 | 0 | $0 |
| Kevin F Mclaughlin | · | 12 sierpnia 2026 M | 18 300 | 0 | 5 | $-1 054 235 |
| Michael Halpin | · | 3 sierpnia 2026 M | 16 394 | 0 | 6 | $-2 043 907 |
| SUDOVAR STEPHEN | · | 17 października 2008 A | 26 900 | 0 | 0 | $0 |
| Robert Bard | · | 7 września 2006 A | 20 100 | 0 | 0 | $0 |
| Brian Hampson | · | 7 września 2006 A | 42 673 | 0 | 0 | $0 |
| Janet Mary Hock | · | 12 maja 2006 M | 37 136 | 0 | 0 | $0 |
| Linda M Fingerle | · | 20 grudnia 2005 S | 6 927 | 0 | 0 | $0 |
| James Andrew Cour | · | 20 września 2005 A | 45 000 | 0 | 0 | $0 |
| Arthur Staubitz | · | 20 grudnia 2004 A | · | 0 | 0 | $0 |
| Joseph A Taylor | · | 10 listopada 2004 A | · | 0 | 0 | $0 |
| Mary L Campbell | · | 21 lipca 2004 P | 1 633 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 45 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2,57% | 271 504 SH | 1 października 2026 | Dziennie |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,11% | 49 341 SH | 1 października 2026 | Dziennie |
| JSMD · Janus Detroit Street Trust | 1,03% | 236 414 NS | 31 lipca 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,96% | 75 417 NS | 31 lipca 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,63% | 4 120 NS | 31 lipca 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,41% | 116 113 NS | 31 lipca 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,38% | 40 581 NS | 31 lipca 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,25% | 60 786 SH | 19 sierpnia 2026 | Dziennie |
| SMDX · Tidal Trust III | 0,22% | 6 148 NS | 31 lipca 2026 | N-PORT |
| IBB · iShares Trust | 0,14% | 386 903 SH | 11 września 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,14% | 55 283 SH | 19 sierpnia 2026 | Dziennie |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,14% | 7 887 SH | 1 października 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3 620 SH | 1 października 2026 | Dziennie |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,13% | 39 214 NS | 31 lipca 2026 | N-PORT |
| IWO · iShares Trust | 0,13% | 483 174 SH | 11 września 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 178 611 SH | 19 sierpnia 2026 | Dziennie |
| PWS · Pacer Funds Trust | 0,11% | 554 NS | 31 lipca 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 13 906 NS | 31 lipca 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 10 519 NS | 31 lipca 2026 | N-PORT |
| RSSL · Global X Funds | 0,08% | 24 683 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 296 573 SH | 19 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,06% | 16 205 SH | 11 września 2026 | Dziennie |
| IWM · iShares Trust | 0,06% | 1 313 242 SH | 11 września 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 3 112 SH | 1 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,05% | 154 432 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 24 418 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 585 506 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 20 190 SH | 1 października 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,03% | 152 527 SH | 19 sierpnia 2026 | Dziennie |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,02% | 9 950 SH | 1 października 2026 | Dziennie |
| WSML · iShares Trust | 0,02% | 3 227 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,01% | 87 592 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3 967 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12 282 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1 999 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 1 620 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 15 414 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 14 707 SH | 9 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 66 394 SH | 11 września 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 617 776 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 108 SH | 19 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | · | 3 113 982 SH | 10 września 2026 | Dziennie |
| IJT · iShares Trust | · | 482 327 SH | 9 września 2026 | Dziennie |
| XJR · iShares Trust | · | 7 051 SH | 31 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | · | 2 325 SH | 11 września 2026 | Dziennie |
VCEL Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 14 analityków
KUP
Średni cel
$59.00
+46,9%
5 35,7%
Mocne kupno
7 50,0%
Kup
2 14,3%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
7 analityków · 2026-09-28Średnia cel $60.57 +50,9%
← Poniżej wszystkich celów
Aktualna cena $40.15
Niski$55.00
Średnia$60.57
Wysoki$72.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| VERA | · | -10.9 | · | · | -55.9% | · |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | · |
| BHVN | $1.50B | -1.6 | · | · | -310.8% | · |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | · |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | · |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | · |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Lip 30, 2026